Sign Up Today and Learn More About Paradromics Stock
Invest in or calculate the value of your shares in Paradromics or other pre-IPO companies through EquityZen's platform.
Paradromics Stock (PARR)
Paradromics is developing high data rate brain computer interfacing technology
About Paradromics Stock
Founded
2015
Headquarters
Austin, TX, US
Industries
Software, Artificial Intelligence, Data and Analytics
Paradromics Press Mentions
Stay in the know about the latest news on Paradromics
Science Corp., Another Braintech Startup Founded By Neuralink Alums, Raises $230M Series C
news • Mar 06, 2026
Fully implantable brain chip aims to restore real speech
foxnews • Nov 27, 2025
When A.I. Listens To Your Thoughts: Speech-Restoring Implants And Who Controls Them
riotimesonline • Nov 24, 2025
Neuralink rival Paradromics cleared to start speech trial
pharmaphorum • Nov 23, 2025
Paradromics Secures FDA Approval for Innovative Brain-Computer Interface Study
synbiobeta • Nov 21, 2025
Paradromics Management
Leadership team at Paradromics
CEO
Matt Angle
Board Member
Amy Kruse
Join now and verify your accreditation status to gain access to:
- Paradromics Current Valuation
- Paradromics Stock Price
- Paradromics Management
- Available deals in Paradromics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Paradromics Cap Table and Funding History by Share Class and Liquidity Preferences
- Paradromics Revenue and Financials
- Paradromics Highlights
- Paradromics Business Model
- Paradromics Risk Factors
- Paradromics Research Report from SACRA Research
Trading Paradromics Stock
How to invest in Paradromics stock?
Accredited investors can buy pre-IPO stock in companies like Paradromics through EquityZen funds. These investments are made available by existing Paradromics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Paradromics stock?
Shareholders can sell their Paradromics stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
